| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | See Remarks
2 companies
Drachman Jonathan G serves as a Director at CALA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 10 buys and 0 sells. Those positions are worth an estimated $333K at current prices.
Historically, Drachman Jonathan G's trades have earned a below-average insider score of 15/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -85.6%.
The biggest single holding is CALA (~$172K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 200,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | Director | Buy | 200,000 | $0.86 | $171,900.00 | New | - | - | ||
| Aug 25, 2021 | NGNE Neurogene Inc. | President And CEO | Buy | 150,000 | $6.22 | $933,550.00 | -120.0% | -17.8% | -81.5% | |
| Jun 4, 2021 | NGNE Neurogene Inc. | President And CEO | Buy | 50,000 | $9.51 | $475,354.00 | +2.3% | -21.5% | -90.2% | |
| Dec 20, 2019 | NGNE Neurogene Inc. | President And CEO | Buy | 119,047 | $8.40 | $999,994.80 | +5.7% | - | - | |
| Sep 11, 2019 | NGNE Neurogene Inc. | See Remarks | Buy | 250,000 | $3.13 | $781,746.58 | +74.8% | - | - |